Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Elixir Department: SOP for Volume Reconciliation During Manufacturing – V 2.0

Posted on By

Elixir Department: SOP for Volume Reconciliation During Manufacturing – V 2.0

Standard Operating Procedure for Volume Reconciliation During Elixir Manufacturing

Department Elixir Department
SOP No. SOP/ELX/199/2025
Supersedes SOP/ELX/199/2022
Page No. Page 1 of 8
Issue Date 11/04/2025
Effective Date 15/04/2025
Review Date 11/04/2026

1. Purpose

To establish a standardized procedure for performing volume reconciliation of elixir formulations at key stages during the manufacturing process to ensure accurate yield calculation, regulatory compliance, and to identify and address any volume discrepancies.

2. Scope

This SOP applies to all stages of elixir batch manufacturing where volume measurement is required — including post-addition of major components, after final blending, post-filtration, and before transfer for filling.

3. Responsibilities

  • Production Operator:
    • Measure and document volume at each defined stage.
    • Notify the supervisor and QA in case of any abnormal deviation.
  • Production Supervisor:
    • Verify measured volumes and calculate expected vs actual reconciliation.
  • QA Officer:
    • Review volume reconciliation records and investigate deviations if necessary.
See also  Elixir Department: SOP for Using Pressure Gauges During Filtration - V 2.0

4. Accountability

The Production Head is accountable for the correctness of volume measurements. QA is accountable for ensuring reconciliation is within acceptable limits and for addressing any discrepancies.

5.

Procedure

5.1 Stage-Wise Reconciliation Points

  1. Volume shall be measured and recorded at the following stages:
    • After addition of purified water and initial dissolution
    • After addition of all active and excipients (pre-final adjustment)
    • After final volume adjustment (before sampling)
    • After bulk transfer to storage or filling tanks

5.2 Method of Volume Measurement

  1. Use calibrated tank-level gauges, dipsticks, flow meters, or sight glass as applicable.
  2. Ensure tank is placed on a level surface and mixing is stopped before measurement.
  3. Refer to calibration chart/scale for accurate volume reading.

5.3 Yield Calculation

  1. Calculate theoretical volume from BMR based on ingredient quantities.
  2. Calculate actual measured volume.
  3. Use the following formula to calculate yield:
    Yield (%) = (Actual Volume / Theoretical Volume) × 100
  4. Acceptable variation: ±2% unless otherwise justified.

5.4 Action in Case of Deviation

  1. Inform QA and investigate for possible causes:
    • Spillage or evaporation
    • Incorrect ingredient quantity or measurement errors
    • Tank dead volume or leakage
  2. Document deviation and initiate corrective action if deviation exceeds limits.

5.5 Documentation

  1. Enter volume measurements and yield calculations in the Volume Reconciliation Logbook (Annexure-1).
  2. Attach a copy to the BMR with supervisor and QA signatures.

6. Abbreviations

  • SOP: Standard Operating Procedure
  • QA: Quality Assurance
  • BMR: Batch Manufacturing Record
  • cGMP: Current Good Manufacturing Practices

7. Documents

  1. Volume Reconciliation Logbook (Annexure-1)
  2. Batch Manufacturing Record (BMR)
  3. Tank Calibration Chart

8. References

  • 21 CFR Part 211.103 – Calculation of Yield
  • WHO TRS 986 – GMP for Pharmaceuticals
  • ICH Q8 – Pharmaceutical Development

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Volume Reconciliation Logbook

Date Batch No. Stage Theoretical Volume (L) Actual Volume (L) Yield (%) Remarks Verified By (QA)
11/04/2025 ELX-0425-018 Final Blend 1000 980 98% Within Limits Sunita Reddy

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
01/01/2024 1.0 Initial Release New SOP QA Head
11/04/2025 2.0 Expanded yield tolerance limits and added dead volume clause Operational Improvement QA Head
Elixers V 2.0 Tags:Elixir colorants, Elixir dosage form, Elixir filtration techniques, Elixir flavoring agents, Elixir formulation, Elixir GMP compliance, Elixir manufacturing process, Elixir manufacturing SOPs, Elixir packaging requirements, Elixir pharmacopoeial standards, Elixir preparation methods, Elixir preservatives, Elixir production equipment, Elixir quality control, Elixir regulatory guidelines, Elixir shelf life, Elixir stability testing, Elixir sterilization methods, Elixir storage conditions, Elixir sweetening agents, Elixir viscosity modifiers, Hydroalcoholic solutions, Medicated elixirs, Non-medicated elixirs, Pharmaceutical elixirs

Post navigation

Previous Post: Gel Manufacturing: SOP for Environmental Monitoring in Gel Production Areas – V 2.0
Next Post: Remote Monitoring of SOP Adherence: New Norms

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version